Detection of eIF4E gene amplification in breast cancer by competitive PCR

Annals of Surgical Oncology

Volumn 5, Issue 3, 1998, Pages 232-237

  Sorrells, Donald L ^a   Black, Destin R ^a   Meschonat, Carol ^a   Rhoads, Robert ^a   De Benedetti, Arrigo ^a   Gao, Mingxing ^a   Williams, B Jill ^a   Li, Benjamin D L ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Amplification; Breast; Cancer; Competitive PCR; EIF4E

Indexed keywords

INITIATION FACTOR; INITIATION FACTOR 4E; ONCOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; BREAST CANCER; DENSITOMETRY; DNA TEMPLATE; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; PEPTIDE INITIATION FACTORS; POLYMERASE CHAIN REACTION; RABBITS; REPRODUCIBILITY OF RESULTS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031810713     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303778     Document Type: Article

References (19)

1. Rhoads R. Regulation of eukaryotic protein synthesis by initiation factors. J Biol Chem 1993;268:3017-20.
2. Sonenberg N. mRNA 5′ cap-binding protein eIF-4E and control of cell growth. In Hershey J, Mathews M, Sonenberg N, eds. Translational control. New York: Cold Spring Harbor Laboratory Press, 1996:245-70.
3. Jansen M, Moor CD, Sussenbach J, Brande JVD. Translational control of gene expression. Pediatr Res 1995;37:681-6.
4. DeBenedetti A. Rhoads R. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 1990;87: 8212-6.
5. Anthony B, Carter P, DeBenedetti A. Overexpression of the protooncogene/translation factor 4E in breast carcinoma cell lines. Int J Cancer 1996;65:1-6.
6. Kerekatte V, Smiley K, Hu B, et al. The proto-oncogene/ translation factor eIF-4e: a survey of its expression in breast carcinomas. Int J Cancer 1995;64:27-31.
7. Kevil C, Carter P, Hu B, DeBenedetti A. Translational enhancement of FGF-2 by cIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogens 1995;11: 2339-48.
8. Rosenwald I, Lazaris-Karatzas A, Sonenberg N, Schmidt E. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993;13:7358-63.
9. Guerin M, Barrois M, Terrier M, et al. Overexpression of either c-myc or c-erB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogens Res 1988;3:32.
10. Slamon D, Godolphin W, Jones L, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244:707-12.
11. Xia W, Lau Y, Zhang H, et al. Strong correlation between c-erbB-2 Overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 1997;3:3-9.
12. Higuchi R. Using PCR to engineer DNA. In: Erlich H, ed. PCR technology: principles and applications for DNA amplification. New York: Stockton Press, 1989:61-70.
13. Li B, Harlow S, Budnick R, et al. Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction. Cancer 1994;73:2771-8.
14. Rychlik W, Domier L, Gardner P, et al. Amino acid sequence of the mRNA cap-binding protein from human tissues. Proc Natl Acad Sci USA 1992;89:1148.
15. Wang A, Mark D. Quantitative PCR. In: Innis M, Gelfand D, Sninsky J, White T, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990:70-5.
16. Champeme MH BI, Hacene K, Lidereau R. Int-2/FGF-3 amplification is a better independent predictor of relapse than c-myc and c-erb-2/neu amplification in primary human breast cancer. Mod Pathol 1994;7:900-5.
17. Li BDL LL, Dawson M, DeBenedetti A. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast cancer. Cancer 1997; 79:2385-90.
18. Levitt S, Aeppli D, Nierengarten M. The importance of local control in the conservative treatment of breast cancer. Acta Oncol 1995;34:839-44.
19. Weinberg R. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989;49:3713-21.